Lifestyle Transformation: Losing a substantial amount of weight provides increased energy, confidence, mobility, mood, reduced joint pain, and an enhanced quality of life
10.1056/NEJMoa2306963 [DOI] [PubMed] [Google Scholar] 79
The SURPASS-CVOT trial is a phase 3, randomized, double-blind cardiovascular outcomes trial that will assess tirzepatide for both non-inferiority and superiority against dulaglutide. For dulaglutide, this effect is already proven: According to the Trulicity website, the drug may be used in adults with type 2 diabetes to reduce the risk of major cardiovascular events (problems having to do with the heart and blood vessels) such as death, heart attack, or stroke in people who have heart disease or multiple cardiovascular risk factors. How do I know which medication is right for me
Lenherr: Depending on how much your bladder is injured, sometimes we have to have patients actually just pass a small catheter every four hours while they're awake to empty their bladder as opposed to trying to pee it out
Strengthened immune system and better overall wellness